Joshua Makower's Net Worth

$0

Who is Joshua Makower?

Joshua Makower does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., Robinhood Markets, Inc., AVEO PHARMACEUTICALS INC, Mirum Pharmaceuticals, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Savara Inc, Trevi Therapeutics, Inc., Annexon, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., Marker Therapeutics, Inc., Achaogen Inc, and IRIDEX CORP.

SEC CIK

Joshua Makower's CIK is 0001235952

Past Insider Trading and Trends

2022 was Joshua Makower's most active year for acquiring shares with 2 total transactions. Joshua Makower's most active month to acquire stocks was the month of September. 2022 saw Joshua Makower paying a total of $0.00 for 148,879 shares, this is the most they've acquired in one year.